Crisaborole API

Xi'an Faithful BioTech Co., Ltd: Your Trusted Crisaborole API Manufacturer & Supplier

Xi'an Faithful BioTech Co., Ltd focuses on the supply of characteristic active pharmaceutical ingredients in the field of dermatology. We not only provide high-quality active pharmaceutical ingredients such as Crisaborole API, but also strive to provide customers with one-stop services. With the concept of honest management and the insistence on product quality, we have gained widespread recognition from customers.

Crisaborole API Introduction

Crisaborole API is a small molecule selective phosphodiesterase 4 (PDE-4) inhibitor that can inhibit PDE-4 activity, increase intracellular cAMP levels, and downregulate the expression of various pro-inflammatory cytokines, thereby exerting anti-inflammatory and immune regulatory effects. Suitable for local topical treatment of mild to moderate atopic dermatitis patients aged 3 months and above.

Specifications 

Application area of Crisaborole API

Core use: Related preparations such as ointments are used to treat mild to moderate atopic dermatitis;
Expanded use:

• Psoriasis: Early research and development have been focused on, and related studies are ongoing.
• Vitiligo: It is listed as one of the potential indications due to its regulatory effect on the immune system.
• Other inflammatory skin diseases, such as seborrheic dermatitis.

Main Advantages 

Accurate and efficient

• It can precisely act on the intracellular inflammatory signaling pathway, effectively reducing the levels of key inflammatory factors such as IL-2, IL-4, IL-13, TNF - α, etc.

Non hormonal, safer

• Does not contain glucocorticoids, long-term use will not cause any side effects, suitable for sensitive areas and patients who need long-term maintenance treatment.

Rapid onset

• As a small molecule compound, it is easy to penetrate the skin barrier and has significant clinical relief.

Widely applicable population

• FDA and NMPA approved for infants and young children as young as 3 months old, covering all age groups of mild to moderate AD patients.

Contact us sales1@faithfulbio.com or Whats App：+86 17782784795

Why choose us

• In terms of quality control, we have established a strict supplier admission mechanism and selected compliant manufacturers as long-term partners to ensure that Crisaborole API drugs meet high-level standards such as CP/EP/USP.
• In terms of service response, our team is available 24 hours a day online to answer your inquiries and questions.
• In terms of supply chain security, relying on a mature warehousing and logistics system, we ensure the safe storage and transportation of products under specified sealed and cool conditions, achieving stable and timely delivery.

Quality Control

R&D Results

Packaging and Transportation

After-Sales Service

Qualification Certification

Exhibition

FAQ

Q1:Is Crisaborole a steroid drug?

A1:No. Crisaborole belongs to the PDE-4 inhibitor class of small molecule anti-inflammatory drugs and does not contain any glucocorticoid components.

Q2:What are the differences between Tacrolimus and Crisaborole in the treatment of atopic dermatitis?

A2:Tacrolimus is like a "powerful heavy fist fighter" with outstanding therapeutic effects, but it has higher requirements for safety, especially requiring doctors to weigh the risks of long-term use. Crisaborole is more like a 'gentle regular athlete', with a smoother onset and a different spectrum of side effects, especially friendly to children and sensitive areas.

Q3:What is the age range for the application of Crisaborole?

A3:Currently approved for topical treatment of mild to moderate atopic dermatitis patients aged 3 months and above.

Contact US

We supply high quality Crisaborole API, contact us sales1@faithfulbio.com or Whats App：+86 17782784795 any time  .